Peak Pharmacy closes Derbyshire branch as funding calls intensify

Peak Pharmacy has announced plans to close one of its branches and merge it with another in the same Derbyshire town as funding pressures continue to bite.

The pharmacy on the town’s high street will close and be merged with another pharmacy

It comes amid urgent calls for more funding for England's community pharmacy sector, with pharmacy leaders warning of mass closures unless the government steps in.

The Peak Pharmacy on Chapel-en-le-Frith's high street will close and be merged with another of the chain's branches on Thornbrook Road later this year, the company confirmed to C+D last week (March 9).

Matt Webster, head of retail operations at the chain, said the two pharmacies are situated within “walking distance”, being located just a “few hundred yards" apart.

It follows a "strategic review" by the chain, which concluded that it "made sense with two pharmacies in very close proximity to each other to consolidate into one premises", he told C+D.

Read more: Patient group: Over-60s ‘overwhelmingly’ prefer indies to supermarket pharmacies

“As is normally healthy of any pharmacy business, you do strategic reviews on a regular basis,” Mr Webster said.

“It’s a relatively isolated decision that we’ve taken but [we] cannot deny that the economic pressures of the sector were a driving force behind us making that decision in that one location,” he continued.

The decision to close the high street branch was not "taken lightly" as it is "very close to Peak Pharmacy's heart", he stressed

“But it was just a location where we felt we could continue to give great service to the town from just one premises instead of the two that we’d been running.”

According to its website, Peak Pharmacy owns over 140 pharmacies.

No job losses

Mr Webster was adamant that no staff would lose their jobs because of the merger.

“The intent all along is for moving all the staff with the patients so to speak so we’re not looking at any job losses as a result of this decision,” he said.

The move will see affected staff move to the Thornbrook road branch so that the pharmacy will “have all of the colleagues in one location rather than two”, he added.

Mr Webster could not confirm an exact date for the merger, although he said “the application has gone in” and it will happen “later this year”.

Peak Pharmacy will ensure patients are "well informed” of the change when there is a “definite date”, he added.

“We guarantee they’ll continue to get great service in the new location,” he stressed.

Funding pressures

It follows urgent calls from sector leaders to improve pharmacy funding, which has stayed at a flat rate since 2017.

For his part, Mr Webster said the “whole sector is under pressure in terms of funding”.

Calls for more funding for the community pharmacy sector have been increasing in recent weeks, with several pharmacy bodies joining forces to campaign on the issue.

Read more: Petition to 'save our pharmacies' tops 1.8k signatures in one day

The campaign's public petition to lobby the government for more funding garnered over 1,800 signatures in just one day.

Earlier this week, the Pharmaceutical Services Negotiating Committee (PSNC) urged the government to pause the rollout of the upcoming Pharmacy Quality Scheme (PQS) unless it invests more money into community pharmacies.

Sign in or register for free

Latest from News

BREAKING: Pharmacies to cut hours and services from April 1

 
• By 
 • comment

The National Pharmacy Association (NPA) has announced that it is advising its 6,000 member pharmacies to limit services and reduce opening hours in protest against “unsustainable” funding.

Sebco coal tar scalp ointment appointed by DHSC to support current shortages

 • comment

Due to shortages in coal tar scalp ointment, the DHSC has asked the manufacturer of an equivalent product - Sebco - to provide increased stock levels to support patients during this time.

Pharmacies to boost naloxone stock amid ‘sudden’ overdose spike

 
• By 
 • comment

Pharmacies in Scotland have been asked to ensure they have the “appropriate stock” of naloxone – a medicine used to reverse the effects of an opiate overdose – following an “increase in sudden collapse” due to overdoses.

More from Business

breaking news

IN FULL: Boots’ parent company sold in $24bn private equity deal

 
• By 
 • comment

Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.

Jhoots accounts: Shareholder funds tumble while debts soar

 
• By 
 • comment

Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.